Corporate Profile & Company Profile
Company name | OSferionBiomaterials Corp. |
---|---|
Representative | Manabu Ishikawa, President |
Head Office | Daiwa Sasazuka Tower, 1-50-1 Sasazuka, Shibuya-ku, Tokyo 151-0073, Japan |
Business activities | Research and development, manufacture and sale of biomaterials(artificial bones etc.), metal implants and related treatment support systems |
Capitalization | 100,000,000 yen |
Shareholder | OrthoActiVolution Holdings, Inc. (a wholly owned subsidiary of Polaris Capital Group Co., Ltd.) |
Business commencement | October 1, 2004 |
Employees | 127(as of August 1,2025) |
Officers | President Manabu Ishikawa Vice President Takao Tabata Director Eiji Shimizu Director Ryoichi Ogawa Director Naohiko Ohno Director Masashi Matsumoto Auditor Ryota Kikkawa Auditor Yuto Sakagami |
Financing bank | Sumitomo Mitsui Banking Corporation、Kiraboshi Bank, Ltd. |
Company History
Sep. 2004 :Established Olympus Biomaterial Corp.
Sep. 2005 :Acquired HAp technologies from Sumitomo Osaka Cement Co., Ltd.
Dec. 2006 :Concluded the joint venture agreement with Terumo Corporation.
Jan. 2007 :Opened the manufacturing facility in Mishima, Shizuoka
Apr. 2007 :Changed the name to Olympus Terumo Biomaterials Corp.
Dec. 2007 :Acquired ISO 13485 certification
Jul. 2009 :Opened Logistics Center in Shinagawa, Tokyo
May 2015 :Opened the second Logistics Center in Fukuoka, Kyushu
Jun. 2015 :Launched our own HTO Plate System successfully, expanding the portfolio of the orthopedic metal implants
Feb. 2016 :Moved the Head Office to Sasazuka, Tokyo
Mar. 2017 :Get MDSAP certificate
Aug. 2020 :Mishima Factory Research and Development Center Acquired ISO14001
Jul. 2023 :GC Co., Ltd. takes over the development, manufacturing, and sales of collagen products and the sales of dental products.
Aug. 2023 :Becoming a wholly owned subsidiary of Olympus
Jul. 2024 :Parent company changed to Polaris Capital Group Co., Ltd.
Aug. 2025 :Merged with PTCJ-6O Holdings Inc.
Company name changed to OSferionBiomaterials Corp.